| 1 |
33438442 | Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPA-Enriched Oral Supplement in Advanced Pancreatic Cancer. | 2022 |
1 |
| 2 |
35232215 | A Head-to-Head Comparison of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE-IT Study. | 2022 Mar 15 |
2 |
| 3 |
33418065 | The ratio of eicosapentaenoic acid to docosahexaenoic acid as a modulator for the cardio-metabolic effects of omega-3 supplements: A meta-regression of randomized clinical trials. | 2021 Mar |
12 |
| 4 |
33745599 | Associations between plasma levels of omega-3 fatty acids and subsequent allergic diseases. | 2021 Apr |
2 |
| 5 |
29993265 | Effects of EPA and DHA on blood pressure and inflammatory factors: a meta-analysis of randomized controlled trials. | 2019 |
4 |
| 6 |
26137879 | Associations of erythrocyte ω-3 fatty acids with biomarkers of ω-3 fatty acids and inflammation in breast tissue. | 2015 Dec 15 |
1 |
| 7 |
25305703 | Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: a randomized, controlled study. | 2014 Oct 20 |
5 |
| 8 |
25519029 | Protective effect of eicosapentaenoic acid on insulin resistance in hyperlipidemic patients and on the postoperative course of cardiac surgery patients: the possible involvement of adiponectin. | 2014 Dec |
1 |
| 9 |
23351824 | Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial: relation with fish intake, circulating biomarkers, and mortality. | 2013 Feb |
2 |
| 10 |
23361365 | Docosahexaenoic acid and eicosapentaenoic acid reduce C-reactive protein expression and STAT3 activation in IL-6-treated HepG2 cells. | 2013 May |
5 |
| 11 |
23268079 | [A case report of advanced gastric cancer with increased C-reactive protein(CRP) and decreased albumin levels: chemotherapy with nutritional supportive care using eicosapentaenoic acid (EPA)-enriched enteral nutrition agent]. | 2012 Nov |
2 |
| 12 |
21427737 | Associations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acids. | 2011 Jul |
1 |
| 13 |
19185299 | Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. | 2009 Aug |
1 |
| 14 |
19461006 | Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease. | 2009 Aug-Sep |
1 |
| 15 |
19628101 | Dietary intakes of alpha-linolenic and linoleic acids are inversely associated with serum C-reactive protein levels among Japanese men. | 2009 Jun |
1 |
| 16 |
19763135 | Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome. | 2009 Nov |
1 |
| 17 |
17192349 | Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome. | 2007 Jan |
1 |
| 18 |
17545695 | Dietary intake of fatty acids and serum C-reactive protein in Japanese. | 2007 May |
1 |
| 19 |
16825699 | Dietary long-chain n-3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products. | 2006 Jul |
1 |
| 20 |
16332649 | Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. | 2005 Dec |
1 |
| 21 |
15514264 | Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. | 2004 Nov |
3 |
| 22 |
12716789 | Insulin resistance, inflammation, and serum fatty acid composition. | 2003 May |
1 |
| 23 |
12821543 | Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. | 2003 Jul 15 |
2 |
| 24 |
9059324 | Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. | 1997 Feb |
5 |